Sun Pharma Advanced Research Company Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sun Pharma Advanced Research Company (SPARC) has informed the exchanges that its trading window will be closed starting April 1, 2026, until 48 hours after the declaration of its audited financial results for the financial year ended March 31, 2026. This is a routine compliance measure under the company's insider trading policy and SEBI regulations. During this period, insiders and designated persons are prohibited from trading in the company's shares. The date of the board meeting to approve the audited results will be communicated later.
This is a standard regulatory compliance filing and does not directly impact shareholders. Investors should note that audited FY26 results are expected to be announced shortly after the window reopens, which could be a key catalyst for the stock.